Key facts
- Hjarta Care’s last known valuation is $5.0M (Dec 2024).
- It has raised $1.3M across 1 recorded rounds; the latest was Seed Round ($850K) in Nov 2024.
- Hjarta Care has filed 1 Form D with the SEC, most recently Nov 2024 ($850K sold to 9 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Hjarta Care
Funding rounds
1 roundsAbout Hjarta Care
Developer of medical equipment designed to support the surgical explant of endovascular stent grafts and self-expanding TAVR (Transcatheter Aortic Valve Replacement) implants. The company offers specialized surgical tools for controlled and atraumatic implant removal during open procedures, enabling surgeons performing explant surgeries to carry out removals safely and effectively while prioritizing patient and physician safety.
- Sector
- Healthcare
- HQ
- Waukesha, WI, United States
- Founded
- 2020
- Employees
- 2
- Website
- hjarta.care/
- Ownership
- Privately Held (backing)
Hjarta Care doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hjarta Care shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hjarta Care in its N-PORT filings yet. We sweep new filings monthly.